[Recording: you must advance to minute 2:45 where the presentation starts]
The presentation reviews terms and analytic methods used in the economic evaluation of healthcare interventions, how US public and private payers consider information on cost and effectiveness in making value-based coverage and reimbursement decisions, and implications for the adoption in clinical practice of new genomic technologies.